Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Figure 2

Plasma CAIX levels (pg/mL) in LABC patients in response to treatment. In patients with LABC, CAIX rose significantly in response to T + S () but not further with anthracycline based therapy (). The rise in response to T + S was primarily in patients with baseline levels below the median. Paired data, (a) , (b) .

(a)

(b)